Drug Approval | June 27, 2022
Astellas’s update on the Fortis clinical trial of AT845 in adults for pompe disease
The FDA informed Astellas that it did not have sufficient information to assess the risks to subjects
The FDA informed Astellas that it did not have sufficient information to assess the risks to subjects
Atik Cameras launches ChemiMOS; A 9MP CMOS camera for scientific applications
Doubling of median overall survival seen in QuANTUM-First results presented at EHA Presidential Symposium
Cloud-native Alissa data analysis SaaS platform empowers clinical labs and researchers to scale operations with parallel analysis of genomic data
Strategic partnership will develop a digital transformation roadmap and create opportunities for co-innovation in healthcare technologies
Objective tracking data combined with cohort data to drive medicine of the future
Wearable patch sensors (smart patches) are rising in popularity, as they offer a wide range of options for medical diagnosis
Novel approach driven by GN Corp Japan with potentials in neurological illnesses
The investigational prescription digital therapeutic uses a combination of sensors, software, and music based on Rhythmic Auditory Stimulation (RAS)
Targeted action improves quality of healing of tendon and suspensory ligament injuries in horses
Subscribe To Our Newsletter & Stay Updated
